Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
YN001 in Coronary Atherosclerosis
NCT06700720Phase 2Terminated
- Sponsor
- Beijing Inno Medicine Co., Ltd.
- Start
- Feb 2026
- Primary completion
- Jul 2026
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of YN001 in Coronary atherosclerosis (CAD), sponsored by Beijing Inno Medicine Co., Ltd.. Started Feb 2026; status: terminated.
02
Drugs
YN001
03
Conditions
Coronary atherosclerosis (CAD)
Beyond the preview
Go deeper on NCT06700720.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06700720.